EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Erratum: First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan

Iraqi Journal of Hematology · 2026-01 · 15 (1) · 143-143

DOI: 10.4103/ijh.ijh_44_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iraqi Journal of Hematology, 2026-01. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Erratum: First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan. Iraqi Journal of Hematology, 15(1), 143-143. https://doi.org/10.4103/ijh.ijh_44_26

Vancouver

Erratum: First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan. Iraqi Journal of Hematology. 2026;15(1):143-143. doi:10.4103/ijh.ijh_44_26

BibTeX
@article{euvimed2026,
  title = {Erratum: First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan},
  journal = {Iraqi Journal of Hematology},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {143--143},
  doi = {10.4103/ijh.ijh_44_26}
}
Kostenlos starten →